XML 18 R78.htm IDEA: XBRL DOCUMENT v2.4.0.8
Related Party Transactions - Additional Information (Detail) (USD $)
In Thousands, except Share data, unless otherwise specified
9 Months Ended 3 Months Ended 9 Months Ended 33 Months Ended 0 Months Ended 0 Months Ended 0 Months Ended 0 Months Ended 3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Dec. 31, 2013
Sep. 30, 2014
Chief Executive Officer
Sep. 30, 2013
Chief Executive Officer
Sep. 30, 2014
Chief Executive Officer
Sep. 30, 2013
Chief Executive Officer
Oct. 31, 2013
Ziopharm Oncology, Inc.
Sep. 30, 2014
Ziopharm Oncology, Inc.
Dec. 17, 2013
Synthetic Biologics, Inc.
Sep. 30, 2014
Synthetic Biologics, Inc.
Dec. 17, 2013
Synthetic Biologics, Inc.
Sep. 30, 2013
Oragenics, Inc.
Sep. 30, 2014
Oragenics, Inc.
Sep. 30, 2013
Oragenics, Inc.
Nov. 20, 2013
Oragenics, Inc.
Share Purchase Rights Plan
Nov. 20, 2013
Oragenics, Inc.
Share Purchase Rights Plan
Oct. 01, 2013
Fibrocell Science, Inc.
Oct. 01, 2013
Fibrocell Science, Inc.
Sep. 30, 2014
Third Security
Sep. 30, 2013
Third Security
Sep. 30, 2014
Third Security
Sep. 30, 2013
Third Security
Sep. 30, 2014
Related party of Trans Ova Genetics, LC
Related Party Transaction [Line Items]                                                
Total amount of expenses reimbursed                                       $ 85 $ 137 $ 173 $ 385  
Compensation expense 1,485 1,163   508 388 1,485 1,163                                  
Common stock purchase commitment                 50,000                              
Shares of common stock purchased from collaborative partners               30,982                                
Purchase commitment                 19,018                              
Maximum percentage of shares of future securities offerings of collaborative partners to which the entity is entitled to purchase                     19.99%     30.00%                    
Additional shares of collaborative partner to which the entity is entitled to purchase on the open market                     10.00%                          
Shares of common stock purchased from collaborative partners                   2,000,000     1,300,000     1,100,000   2,439,024            
Price per share of common shares                       $ 1.00     $ 3.00   $ 2.50   $ 4.10          
Related party receivables 11,673   5,285                                         1,213
Related party payables $ 1,159   $ 1,605                                         $ 1,055